United States Controlled Release Drug Market Report 2017

Date : Oct 2017

Formats :
Report Code : PMR110730

Category : Pharmaceutical and Healthcare
No Of Pages : 110
In this report, the United States Controlled Release Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales volume, revenue value, market share and growth rate of Controlled Release Drug in these regions, from 2012 to 2022 forecast.

United States Controlled Release Drug market competition by top manufacturers/players, with Controlled Release Drug sales volume, price, revenue Million USD and market share for each manufacturer/player; the top players including
Allergan
BioAlliance Pharma
Collegium Pharmaceutical
Controlled Therapeutics
Cosmo Pharmaceuticals
Egalet
Encore Therapeutics
Flamel Technologies
GlaxoSmithKline
iCeutica
Novartis
Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Pills
Capsules
Injectable Drug Carriers
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Respiratory disease
Digestive Disease
Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents

United States Controlled Release Drug Market Report 2017
1 Controlled Release Drug Overview
1.1 Product Overview and Scope of Controlled Release Drug
1.2 Classification of Controlled Release Drug by Product Category
1.2.1 United States Controlled Release Drug Market Size Sales Volume Comparison by Type 20122022
1.2.2 United States Controlled Release Drug Market Size Sales Volume Market Share by Type Product Category in 2016
1.2.3 Pills
1.2.4 Capsules
1.2.5 Injectable Drug Carriers
1.2.6 Others
1.3 United States Controlled Release Drug Market by Application/End Users
1.3.1 United States Controlled Release Drug Market Size Consumption and Market Share Comparison by Application 20122022
1.3.2 Respiratory disease
1.3.3 Digestive Disease
1.3.4 Others
1.4 United States Controlled Release Drug Market by Region
1.4.1 United States Controlled Release Drug Market Size Value Comparison by Region 20122022
1.4.2 The West Controlled Release Drug Status and Prospect 20122022
1.4.3 Southwest Controlled Release Drug Status and Prospect 20122022
1.4.4 The Middle Atlantic Controlled Release Drug Status and Prospect 20122022
1.4.5 New England Controlled Release Drug Status and Prospect 20122022
1.4.6 The South Controlled Release Drug Status and Prospect 20122022
1.4.7 The Midwest Controlled Release Drug Status and Prospect 20122022
1.5 United States Market Size Value and Volume of Controlled Release Drug 20122022
1.5.1 United States Controlled Release Drug Sales and Growth Rate 20122022
1.5.2 United States Controlled Release Drug Revenue and Growth Rate 20122022

2 United States Controlled Release Drug Market Competition by Players/Suppliers
2.1 United States Controlled Release Drug Sales and Market Share of Key Players/Suppliers 20122017
2.2 United States Controlled Release Drug Revenue and Share by Players/Suppliers 20122017
2.3 United States Controlled Release Drug Average Price by Players/Suppliers 20122017
2.4 United States Controlled Release Drug Market Competitive Situation and Trends
2.4.1 United States Controlled Release Drug Market Concentration Rate
2.4.2 United States Controlled Release Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Controlled Release Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Controlled Release Drug Sales Volume and Revenue Value by Region 20122017
3.1 United States Controlled Release Drug Sales and Market Share by Region 20122017
3.2 United States Controlled Release Drug Revenue and Market Share by Region 20122017
3.3 United States Controlled Release Drug Price by Region 20122017

4 United States Controlled Release Drug Sales Volume and Revenue Value by Type Product Category 20122017
4.1 United States Controlled Release Drug Sales and Market Share by Type Product Category 20122017
4.2 United States Controlled Release Drug Revenue and Market Share by Type 20122017
4.3 United States Controlled Release Drug Price by Type 20122017
4.4 United States Controlled Release Drug Sales Growth Rate by Type 20122017

5 United States Controlled Release Drug Sales Volume by Application 20122017
5.1 United States Controlled Release Drug Sales and Market Share by Application 20122017
5.2 United States Controlled Release Drug Sales Growth Rate by Application 20122017
5.3 Market Drivers and Opportunities

6 United States Controlled Release Drug Players/Suppliers Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Controlled Release Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.1.4 Main Business/Business Overview
6.2 BioAlliance Pharma
6.2.2 Controlled Release Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 BioAlliance Pharma Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.2.4 Main Business/Business Overview
6.3 Collegium Pharmaceutical
6.3.2 Controlled Release Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Collegium Pharmaceutical Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.3.4 Main Business/Business Overview
6.4 Controlled Therapeutics
6.4.2 Controlled Release Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Controlled Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.4.4 Main Business/Business Overview
6.5 Cosmo Pharmaceuticals
6.5.2 Controlled Release Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Cosmo Pharmaceuticals Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.5.4 Main Business/Business Overview
6.6 Egalet
6.6.2 Controlled Release Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Egalet Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.6.4 Main Business/Business Overview
6.7 Encore Therapeutics
6.7.2 Controlled Release Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Encore Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.7.4 Main Business/Business Overview
6.8 Flamel Technologies
6.8.2 Controlled Release Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Flamel Technologies Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline
6.9.2 Controlled Release Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 GlaxoSmithKline Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.9.4 Main Business/Business Overview
6.10 iCeutica
6.10.2 Controlled Release Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 iCeutica Controlled Release Drug Sales, Revenue, Price and Gross Margin 20122017
6.10.4 Main Business/Business Overview
6.11 Novartis
6.12 Pfizer

7 Controlled Release Drug Manufacturing Cost Analysis
7.1 Controlled Release Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Controlled Release Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Controlled Release Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Controlled Release Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Controlled Release Drug Market Size Value and Volume Forecast 20172022
11.1 United States Controlled Release Drug Sales Volume, Revenue Forecast 20172022
11.2 United States Controlled Release Drug Sales Volume Forecast by Type 20172022
11.3 United States Controlled Release Drug Sales Volume Forecast by Application 20172022
11.4 United States Controlled Release Drug Sales Volume Forecast by Region 20172022

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures

Figure Product Picture of Controlled Release Drug
Figure United States Controlled Release Drug Market Size K Pcs by Type 20122022
Figure United States Controlled Release Drug Sales Volume Market Share by Type Product Category in 2016
Figure Pills Product Picture
Figure Capsules Product Picture
Figure Injectable Drug Carriers Product Picture
Figure Others Product Picture
Figure United States Controlled Release Drug Market Size K Pcs by Application 20122022
Figure United States Sales Market Share of Controlled Release Drug by Application in 2016
Figure Respiratory disease Examples
Table Key Downstream Customer in Respiratory disease
Figure Digestive Disease Examples
Table Key Downstream Customer in Digestive Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Controlled Release Drug Market Size Million USD by Region 20122022
Figure The West Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure Southwest Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure The Middle Atlantic Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure New England Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure The South of US Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure The Midwest Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure United States Controlled Release Drug Sales K Pcs and Growth Rate 20122022
Figure United States Controlled Release Drug Revenue Million USD and Growth Rate 20122022
Figure United States Controlled Release Drug Market Major Players Product Sales Volume K Pcs 20122017
Table United States Controlled Release Drug Sales K Pcs of Key Players/Suppliers 20122017
Table United States Controlled Release Drug Sales Share by Players/Suppliers 20122017
Figure 2016 United States Controlled Release Drug Sales Share by Players/Suppliers
Figure 2017 United States Controlled Release Drug Sales Share by Players/Suppliers
Figure United States Controlled Release Drug Market Major Players Product Revenue Million USD 20122017
Table United States Controlled Release Drug Revenue Million USD by Players/Suppliers 20122017
Table United States Controlled Release Drug Revenue Share by Players/Suppliers 20122017
Figure 2016 United States Controlled Release Drug Revenue Share by Players/Suppliers
Figure 2017 United States Controlled Release Drug Revenue Share by Players/Suppliers
Table United States Market Controlled Release Drug Average Price USD/Pcs of Key Players/Suppliers 20122017
Figure United States Market Controlled Release Drug Average Price USD/Pcs of Key Players/Suppliers in 2016
Figure United States Controlled Release Drug Market Share of Top 3 Players/Suppliers
Figure United States Controlled Release Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Controlled Release Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Controlled Release Drug Product Category
Table United States Controlled Release Drug Sales K Pcs by Region 20122017
Table United States Controlled Release Drug Sales Share by Region 20122017
Figure United States Controlled Release Drug Sales Share by Region 20122017
Figure United States Controlled Release Drug Sales Market Share by Region in 2016
Table United States Controlled Release Drug Revenue Million USD and Market Share by Region 20122017
Table United States Controlled Release Drug Revenue Share by Region 20122017
Figure United States Controlled Release Drug Revenue Market Share by Region 20122017
Figure United States Controlled Release Drug Revenue Market Share by Region in 2016
Table United States Controlled Release Drug Price USD/Pcs by Region 20122017
Table United States Controlled Release Drug Sales K Pcs by Type 20122017
Table United States Controlled Release Drug Sales Share by Type 20122017
Figure United States Controlled Release Drug Sales Share by Type 20122017
Figure United States Controlled Release Drug Sales Market Share by Type in 2016
Table United States Controlled Release Drug Revenue Million USD and Market Share by Type 20122017
Table United States Controlled Release Drug Revenue Share by Type 20122017
Figure Revenue Market Share of Controlled Release Drug by Type 20122017
Figure Revenue Market Share of Controlled Release Drug by Type in 2016
Table United States Controlled Release Drug Price USD/Pcs by Types 20122017
Figure United States Controlled Release Drug Sales Growth Rate by Type 20122017
Table United States Controlled Release Drug Sales K Pcs by Application 20122017
Table United States Controlled Release Drug Sales Market Share by Application 20122017
Figure United States Controlled Release Drug Sales Market Share by Application 20122017
Figure United States Controlled Release Drug Sales Market Share by Application in 2016
Table United States Controlled Release Drug Sales Growth Rate by Application 20122017
Figure United States Controlled Release Drug Sales Growth Rate by Application 20122017
Table Allergan Basic Information List
Table Allergan Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Allergan Controlled Release Drug Sales Growth Rate 20122017
Figure Allergan Controlled Release Drug Sales Market Share in United States 20122017
Figure Allergan Controlled Release Drug Revenue Market Share in United States 20122017
Table BioAlliance Pharma Basic Information List
Table BioAlliance Pharma Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure BioAlliance Pharma Controlled Release Drug Sales Growth Rate 20122017
Figure BioAlliance Pharma Controlled Release Drug Sales Market Share in United States 20122017
Figure BioAlliance Pharma Controlled Release Drug Revenue Market Share in United States 20122017
Table Collegium Pharmaceutical Basic Information List
Table Collegium Pharmaceutical Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Collegium Pharmaceutical Controlled Release Drug Sales Growth Rate 20122017
Figure Collegium Pharmaceutical Controlled Release Drug Sales Market Share in United States 20122017
Figure Collegium Pharmaceutical Controlled Release Drug Revenue Market Share in United States 20122017
Table Controlled Therapeutics Basic Information List
Table Controlled Therapeutics Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Controlled Therapeutics Controlled Release Drug Sales Growth Rate 20122017
Figure Controlled Therapeutics Controlled Release Drug Sales Market Share in United States 20122017
Figure Controlled Therapeutics Controlled Release Drug Revenue Market Share in United States 20122017
Table Cosmo Pharmaceuticals Basic Information List
Table Cosmo Pharmaceuticals Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Growth Rate 20122017
Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Market Share in United States 20122017
Figure Cosmo Pharmaceuticals Controlled Release Drug Revenue Market Share in United States 20122017
Table Egalet Basic Information List
Table Egalet Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Egalet Controlled Release Drug Sales Growth Rate 20122017
Figure Egalet Controlled Release Drug Sales Market Share in United States 20122017
Figure Egalet Controlled Release Drug Revenue Market Share in United States 20122017
Table Encore Therapeutics Basic Information List
Table Encore Therapeutics Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Encore Therapeutics Controlled Release Drug Sales Growth Rate 20122017
Figure Encore Therapeutics Controlled Release Drug Sales Market Share in United States 20122017
Figure Encore Therapeutics Controlled Release Drug Revenue Market Share in United States 20122017
Table Flamel Technologies Basic Information List
Table Flamel Technologies Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure Flamel Technologies Controlled Release Drug Sales Growth Rate 20122017
Figure Flamel Technologies Controlled Release Drug Sales Market Share in United States 20122017
Figure Flamel Technologies Controlled Release Drug Revenue Market Share in United States 20122017
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure GlaxoSmithKline Controlled Release Drug Sales Growth Rate 20122017
Figure GlaxoSmithKline Controlled Release Drug Sales Market Share in United States 20122017
Figure GlaxoSmithKline Controlled Release Drug Revenue Market Share in United States 20122017
Table iCeutica Basic Information List
Table iCeutica Controlled Release Drug Sales K Pcs, Revenue Million USD, Price USD/Pcs and Gross Margin 20122017
Figure iCeutica Controlled Release Drug Sales Growth Rate 20122017
Figure iCeutica Controlled Release Drug Sales Market Share in United States 20122017
Figure iCeutica Controlled Release Drug Revenue Market Share in United States 20122017
Table Novartis Basic Information List
Table Pfizer Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Controlled Release Drug
Figure Manufacturing Process Analysis of Controlled Release Drug
Figure Controlled Release Drug Industrial Chain Analysis
Table Raw Materials Sources of Controlled Release Drug Major Players/Suppliers in 2016
Table Major Buyers of Controlled Release Drug
Table Distributors/Traders List
Figure United States Controlled Release Drug Sales Volume K Pcs and Growth Rate Forecast 20172022
Figure United States Controlled Release Drug Revenue Million USD and Growth Rate Forecast 20172022
Figure United States Controlled Release Drug Price USD/Pcs Trend Forecast 20172022
Table United States Controlled Release Drug Sales Volume K Pcs Forecast by Type 20172022
Figure United States Controlled Release Drug Sales Volume K Pcs Forecast by Type 20172022
Figure United States Controlled Release Drug Sales Volume K Pcs Forecast by Type in 2022
Table United States Controlled Release Drug Sales Volume K Pcs Forecast by Application 20172022
Figure United States Controlled Release Drug Sales Volume K Pcs Forecast by Application 20172022
Figure United States Controlled Release Drug Sales Volume K Pcs Forecast by Application in 2022
Table United States Controlled Release Drug Sales Volume K Pcs Forecast by Region 20172022
Table United States Controlled Release Drug Sales Volume Share Forecast by Region 20172022
Figure United States Controlled Release Drug Sales Volume Share Forecast by Region 20172022
Figure United States Controlled Release Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottomup and Topdown Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “United States Controlled Release Drug Market" Which offers essential information based on fresh ideas into United States Controlled Release Drug Market industry along with unique market analysis which covers current top Manufactures in United States Controlled Release Drug Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim United States Controlled Release Drug Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.


Similar Reports

States Cellulose Acetate Fiber Market Insights 2019, Global and Chinese Analysis and Forecast to 2024... July 2019 Request Sample
United StatesBicycle Handlebars Market Insights 2019, Global and Chinese Analysis and Forecast to 2024... July 2019 Request Sample
States Outdoor Sports GPS Device Market Insights 2019, Global and Chinese Analysis and Forecast to 2024... July 2019 Request Sample
States Aluminum Alloy Automotive Wheels Market Insights 2019, Global and Chinese Analysis and Forecast to 2... July 2019 Request Sample